U.S., May 31 -- ClinicalTrials.gov registry received information related to the study (NCT06997185) titled 'Communicating Uncertainties Associated With the Benefits and Risks of New Cancer Drugs' on May 09.
Brief Summary: This nationally representative randomized survey of US adults will evaluate the effect of using brief statements to communicate different sources of uncertainty about the benefits and harms of new cancer drugs on participants' decisions and understanding.
Study Start Date: May 09
Study Type: INTERVENTIONAL
Condition:
Cancer
Intervention:
OTHER: Statement communicating uncertainty with a single arm trial
Because Zenova has not been compared to other treatments, it is unknown if Zenova is better, the same, or worse t...